Duvelisib in Combination With Nivolumab in Patients With Advanced Unresectable Melanoma
Clinical trial NCT04688658 · TERMINATED
Trial details
- NCT number
- NCT04688658
- Sponsor
- John Kirkwood
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-06
- Primary completion
- 2024-02-22
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.